Appendix CSearch Strategy for Grey Literature

Publication Details

Regulatory Information

Clinical trial registries

  • NIH database
    Date searched: 5/15/2012
    Search strategy: PCA3 [ALL-FIELDS] AND “Completed” [OVERALL-STATUS]
    Records: 6
  • BioMed central
    Date searched: 8/15/2011
    Search strategy: “PCA3” for completed trials
    Records: 0
  • WHO International Clinical Trials Registry Platform Search Portal
    Date searched: 8/15/2011
    Search strategy: Search String = “PCA3” for ALL recruitment status trials
    Records: 0

Conference papers and abstracts

Organizations publishing Guidance or Review Documents

  • Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • Australia and New Zealand Horizon Scanning Network (ANZHSN)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • Canadian Agency for Drugs and Technologies in Health (CADTH)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 3 (all excluded; not relevant)
  • The Cochrane Collaboration (Cochrane)
    Date searched: 8/15/2011
    Search strategy: search string string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR“differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • European network for Health Technology Assessment (EUnetHTA)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • EuroGenTest
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 0
  • National Guideline Clearinghouse (NGC)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”). – searches done in different combinations using the above combinations.
    Records: 4
  • National Institute for Clinical Excellence (NICE)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 1 (excluded; not relevant)
  • United Kingdom Health Technology Assessment Programme (UK HTA)
    Date searched: 8/15/2011
    Search strategy: search string (“PCA3” OR “prostate cancer antigen 3” OR “DD3” OR “differential display code 3” OR “biomarkers”) AND (“prostate cancer” OR “prostatic cancer”).
    Records: 7

Government documents

Manufacturer database

  • Source: GenProbe Response to the Request for Scientific Information
    Date posted: 12/7/2011
    Date searched: Not applicable
    Search strategy: Not applicable
    Records: 27

References for Review and Abstraction from the Grey Literature Search

PUBMED ID: NA

Authors: Submitted by Gen-Probe, Inc.

Title: Summary of Safety and Effectiveness Data: PROGENSA PCA3 Assay.

Citation: U.S. Food and Drug Administration, http://www.accessdata.fda.gov/cdrh_docs/pdf10/P100033b.pdf, accessed June 1, 2012.

Selected Test Manufacturers for Contact.

Table

Selected Test Manufacturers for Contact.

Contact Information.

Table

Contact Information.